Protein associated with ALS points to possible targets for therapeutic intervention

Scientists at the University of Alberta may have found possible targets for therapeutic interventions in the fight against Lou Gehrig’s disease. Biophysicist Michael Woodside and his research team conducted the

Potential window for treating ALS identified

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that affects as many as 30,000 people in the United States, with 5,000 new cases diagnosed each year. It weakens muscles over

RSV shown to infect nerve cells, cause inflammation and damage

Respiratory syncytial virus (RSV), a common infection in children and senior adults, can also infect nerve cells and trigger inflammation leading to nerve damage, according to a new Tulane University